New Research Reveals Gut Bacteria's Contagious Nature and Complexity
The human gut hosts trillions of microorganisms, collectively known as the microbiome, which play a crucial role in digestion, immune function, and metabolism. Recent research led by the University of Vienna has revealed that many gut bacterial species are more intricate than previously thought. Utilizing a technique termed 'reverse ecology,' the researchers demonstrated that individual bacterial species can harbor multiple evolutionarily distinct populations, each adapted to specific conditions within the gut. Some of these populations have been linked to advanced age, chronic inflammatory bowel diseases, colorectal cancer, and type 2 diabetes.
Published in the journal Nature, these findings may aid scientists in pinpointing more precise microbiome biomarkers and could eventually lead to treatments targeting specific bacterial populations rather than entire species. Traditionally, microbiome research has categorized bacteria by species or broad genetic similarities, which, while useful, often overlooks significant differences among populations adapted to various environments within the human body. This oversight complicates the determination of which bacteria are genuinely associated with diseases, which are merely coincidental, and which may offer protective benefits.
To address this, the researchers sought to identify biologically meaningful bacterial groups by examining evidence of adaptation and specialization within the gut. They analyzed thousands of bacterial isolates from the human gut, alongside extensive metagenomic data from diverse populations across multiple countries, age groups, and health statuses. Metagenomic data encompasses the complete genetic information of microbial communities from the samples.
The research team developed a bioinformatic method based on reverse ecology to infer how organisms have adapted to their specific environments. They aimed to identify genetic signatures indicating that certain bacterial populations had successfully adapted to particular ecological niches within the gut.
An important finding emerged from the observation of 'genome-wide selective sweeps,' which occur when a beneficial mutation provides an advantage to an individual, allowing its descendants to dominate. This process reduces genetic diversity within the successful population while creating groups that are highly similar in ancestry and biological function, thus making them easier to distinguish from neighboring populations.
The analysis revealed that many well-known gut bacterial species actually comprise several distinct evolutionary lineages, each better suited to different conditions within the gut. Lead author Xiaoqian Annie Yu from the Centre for Microbiology and Environmental Systems Science at the University of Vienna stated, "If you don't just count species but take evolutionary adaptation into account, you can identify the biologically relevant units in the microbiome much more accurately. Even within the same bacterial species, some populations occur more frequently than others in certain diseases, which often remains hidden when all are considered together."
Moreover, the researchers discovered that particularly competitive bacterial populations can spread rapidly across vast geographic distances, with some populations appearing to have expanded across continents in just a few decades. Such patterns have previously been observed primarily among pathogens, making this finding particularly significant for ordinary gut bacteria.
Study leader Martin F. Polz emphasized, "Our findings show that gut bacteria are also more dynamic than previously thought. Well-adapted strains can spread internationally and occupy new ecological niches." This research suggests that the gut microbiome is influenced by more than just diet, medication, and lifestyle; transmission between individuals may also play a crucial role in determining which bacterial populations are established and proliferate.
These discoveries could transform how researchers link gut bacteria to diseases. Instead of treating entire bacterial species as a single entity, scientists may eventually focus on specific populations most relevant to health. This added precision could enhance the search for biomarkers and, over time, lead to more targeted therapies aimed at encouraging beneficial bacterial strains while suppressing those associated with adverse effects. The researchers plan to further investigate the genetic differences that separate these bacterial populations and the biological functions those differences produce.




